Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SDI Limited (SDI.AX)
AUD1.40
+0.00 (+0.14%)
AU ASX Healthcare Medical - Instruments & Supplies
Address
3-15 Brunsdon Street 3153
Bayswater, VIC, AU
Bayswater, VIC, AU
CEO
Samantha Jane Cheetham
Website
sdi.com.au
IPO
1999-01-04
ISIN AU000000SDI2
Description
SDI Limited, an Australian company, specializes in the development, manufacturing, and global distribution of diverse dental materials. Their core business encompasses dental restorative solutions, tooth whitening systems, and a wide array of other dental supplies. The product portfolio includes bonding agents, dental alloys, cements, composite resins, etching gels, glass ionomer cements, dental sealants, and treatments for tooth sensitivity, in addition to their whitening range. The company also supplies essential dental equipment and related accessories. SDI's offerings reach an international market through a network of distributors, authorized dealers, and direct sales to dental practitioners. Founded in 1972, the firm's main office is situated in Bayswater, Australia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD1.40
+0.00 (+0.14%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
167.9K
Beta
-0.36
Float Shares
44.49M
Free Float %
37.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.74% | -0.37% | +10.16% | +53.11% | +42.63% | +48.09% | +62.28% | +67.28% | +50.56% | +160.58% | +2,319.64% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.40
DCF (Unlevered)
1.51
+7.8%
DCF (Levered)
4.46
+219.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2025-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.67
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
4 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-0.7% Q4'25: +1.3% (vs Q4'23)
-
EPS growth Medical - Instruments & Supplies: +16.3%+14.0% Q4'25: -12.2% (vs Q4'23)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+11.8% Q4'25: +2.9% (vs Q4'23)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+14.0% ★ Q4'25: +12.0% (vs Q4'23)
-
ROIC Medical - Instruments & Supplies: +6.0%+11.2% ★ Q4'25: +16.4% (vs Q4'23)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.0% Q4'25: 0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×0.95× Q4'25: 0.46× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2004 actual |
Jun 2005 actual |
Jun 2006 actual |
Jun 2007 actual |
Jun 2008 actual |
Jun 2009 actual |
Jun 2010 actual |
Jun 2011 actual |
Jun 2012 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
43.35M
est: 43.22M (+0.3%)
|
45.94M
est: 46.90M (-2.1%)
|
45.15M
est: 48.25M (-6.4%)
|
48.61M
est: 49.03M (-0.9%)
|
49.08M
est: 49.36M (-0.6%)
|
56.50M
est: 56.93M (-0.8%)
|
53.09M
est: 58.00M (-8.5%)
|
54.98M
est: 51.91M (+5.9%)
|
56.68M
est: 56.58M (+0.2%)
|
74.07M
est: 74.10M (0.0%)
|
74.54M
est: 75.60M (-1.4%)
|
79.60M
est: 77.80M (+2.3%)
|
67.37M
est: 74.10M (-9.1%)
|
81.65M
est: 75.60M (+8.0%)
|
95.15M
est: 77.80M (+22.3%)
|
107.86M
est: 104.85M (+2.9%)
|
111.21M
est: 111.40M (-0.2%)
|
110.38M
est: 111.00M (-0.6%)
|
115.90M
115.90M – 115.90M
+4.4% YoY
|
123.60M
123.60M – 123.60M
+6.6% YoY
|
131.10M
131.10M – 131.10M
+6.1% YoY
|
| EBITDA |
13.10M
est: 7.45M (+75.8%)
|
5.34M
est: 9.33M (-42.7%)
|
8.85M
est: 164.6K (+5,274.4%)
|
8.30M
est: 6.51M (+27.4%)
|
4.68M
est: 5.68M (-17.5%)
|
7.80M
est: 9.62M (-19.0%)
|
7.15M
est: 9.80M (-27.1%)
|
4.36M
est: 4.79M (-9.1%)
|
5.61M
est: 9.75M (-42.5%)
|
12.50M
est: 12.77M (-2.1%)
|
12.18M
est: 13.03M (-6.6%)
|
14.19M
est: 13.41M (+5.8%)
|
9.80M
est: 12.77M (-23.3%)
|
16.84M
est: 13.03M (+29.2%)
|
14.76M
est: 13.41M (+10.0%)
|
15.73M
est: 18.07M (-13.0%)
|
20.96M
est: 19.20M (+9.1%)
|
18.36M
est: 19.13M (-4.1%)
|
19.98M
19.98M – 19.98M
+4.4% YoY
|
21.31M
21.31M – 21.31M
+6.6% YoY
|
22.60M
22.60M – 22.60M
+6.1% YoY
|
| EBIT |
11.33M
est: 5.65M (+100.5%)
|
3.09M
est: 9.33M (-66.9%)
|
7.38M
est: 164.6K (+4,381.9%)
|
6.53M
est: 6.51M (+0.3%)
|
2.64M
est: 5.68M (-53.5%)
|
5.56M
est: 7.30M (-23.9%)
|
4.93M
est: 7.44M (-33.7%)
|
2.03M
est: 4.80M (-57.7%)
|
3.02M
est: 7.40M (-59.2%)
|
8.41M
est: 9.69M (-13.2%)
|
8.31M
est: 9.89M (-16.0%)
|
10.52M
est: 10.18M (+3.4%)
|
5.12M
est: 9.69M (-47.1%)
|
12.26M
est: 9.89M (+24.0%)
|
10.17M
est: 10.18M (0.0%)
|
11.45M
est: 13.71M (-16.5%)
|
16.74M
est: 16.82M (-0.5%)
|
15.44M
est: 16.76M (-7.9%)
|
17.50M
17.50M – 17.50M
+4.4% YoY
|
18.67M
18.67M – 18.67M
+6.6% YoY
|
19.80M
19.80M – 19.80M
+6.1% YoY
|
| Net Income |
8.03M
est: 8.67M (-7.4%)
|
2.15M
est: 6.26M (-65.7%)
|
5.12M
est: 20.6K (+24,780.9%)
|
4.06M
est: 5.20M (-22.0%)
|
1.13M
est: 4.09M (-72.4%)
|
3.12M
est: 2.65M (+17.5%)
|
3.47M
est: 3.38M (+2.8%)
|
1.21M
est: 3.77M (-68.0%)
|
1.97M
|
5.58M
est: 5.59M (-0.2%)
|
5.66M
est: 5.82M (-2.8%)
|
7.33M
est: 6.42M (+14.2%)
|
4.24M
est: 5.59M (-24.2%)
|
8.94M
est: 5.82M (+53.5%)
|
7.28M
est: 6.42M (+13.4%)
|
7.06M
est: 7.13M (-1.1%)
|
10.42M
est: 10.70M (-2.6%)
|
12.16M
est: 10.14M (+19.9%)
|
11.29M
11.29M – 11.29M
+11.3% YoY
|
11.89M
11.89M – 11.89M
+5.3% YoY
|
12.72M
12.72M – 12.72M
+7.0% YoY
|
| SGA |
16.84M
est: 18.69M (-9.9%)
|
21.26M
est: 18.28M (+16.3%)
|
21.20M
est: 21.87M (-3.1%)
|
21.88M
est: 21.48M (+1.8%)
|
23.87M
est: 22.03M (+8.4%)
|
26.12M
est: 24.13M (+8.2%)
|
24.14M
est: 24.59M (-1.8%)
|
24.50M
est: 26.22M (-6.6%)
|
24.08M
est: 24.47M (-1.6%)
|
32.83M
est: 32.04M (+2.4%)
|
34.40M
est: 32.69M (+5.2%)
|
38.03M
est: 33.64M (+13.0%)
|
33.38M
est: 32.04M (+4.2%)
|
33.28M
est: 32.69M (+1.8%)
|
40.81M
est: 33.64M (+21.3%)
|
47.63M
est: 45.34M (+5.0%)
|
47.47M
est: 48.18M (-1.5%)
|
50.47M
est: 48.00M (+5.1%)
|
50.12M
50.12M – 50.12M
+4.4% YoY
|
53.45M
53.45M – 53.45M
+6.6% YoY
|
56.69M
56.69M – 56.69M
+6.1% YoY
|
| EPS |
0.07
est: 0.07 (-5.9%)
|
0.02
est: 0.02 (+8.0%)
|
0.04
est: 0.04 (+4.5%)
|
0.03
est: 0.04 (-9.8%)
|
0.01
est: 0.01 (-23.8%)
|
0.03
est: 0.02 (+17.0%)
|
0.03
est: 0.03 (+2.5%)
|
0.01
|
0.02
|
0.05
est: 0.05 (-0.2%)
|
0.05
est: 0.05 (-2.9%)
|
0.06
est: 0.05 (+14.3%)
|
0.04
est: 0.05 (-24.3%)
|
0.08
est: 0.05 (+53.5%)
|
0.06
est: 0.05 (+13.3%)
|
0.06
est: 0.06 (-1.0%)
|
0.09
est: 0.09 (-2.6%)
|
0.10
est: 0.09 (+17.2%)
|
0.10
0.10 – 0.10
+11.3% YoY
|
0.10
0.10 – 0.10
+5.3% YoY
|
0.11
0.11 – 0.11
+7.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-25 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
22.42M
OE per share TTM
0.19
Owner's Yield
13.87%
Maintenance CapEx ratio
40.04%
Maint CapEx / Avg PPE
33.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
56.1K
Shares Outstanding
118.87M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Samantha Jane Cheetham | Chief Executive Officer, MD & Executive Director | 849.5K | female |
| John Joseph Slaviero | Chief Financial Officer, Chief Operating Officer, Company Secretary & Executive Director | 785.0K | male |
| Nicholas Alexander Cheetham | Chief Information Officer and Operations & IT Director | 347.4K | male |
| Ray Cahill | Chief Quality & Compliance Officer | 231.3K | male |
| Jeffery James Cheetham | Founder & Chairman | 177.0K | male |
| Thomas Cheetham | Sales Manager of Australia, New Zealand & South Africa | 100.0K | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SDI.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
